. 2018 Jan 19;9(11):10042–10053. doi: 10.18632/oncotarget.24273

Table 1. Patient data.

Patient ID	Angio Type	age dx	Angio Surgery type	grade	chemo	LR	DM	Interval (month)	Earlier Breast Cancer
Patient ID	Angio Type	age dx	Angio Surgery type	grade	chemo	LR	DM	Interval (month)	Stage	ER/PR/Her2	chemo	hormones	XRT
AX5612	Rad-Ind	74	simple mastectomy	3	no	+	–	109	IA	+ / ND / ND	no	novaldex	WBI
AX5613	Rad-Ind	77	simple mastectomy	3	no	+	–	87	IA	+ / ND / –	no	tamoxifen	WBI
AX5617	Rad-Ind	86	incisional biopsies only	3	no (refused)	–	–	68	IA	98% / 2% / 0+	no	no	WBI
AX5618	Rad-Ind	59	mastectomy	2	doxycycline, ifosfamide, mesnax4	+	+	162	IA	94% / ND / ND	no	tamoxifen	WBI
AX5615	Rad-Ind	74	simple mastectomy	3	no	–	–	81	IIA	1% / 2% / ND	no	no	WBI
AX5626	Rad-Ind	75	simple mastectomy	3	no	–	–	105	IA	– / – / ND	no	tamoxifen	WBI
AX5625	Rad-Ind	62	simple mastectomy	3	yes (unknown)	–	–	75	IA	99%/12%/0+	no	arimidex	WBI
AX5622	Rad-Ind	^**	mastectomy	^**	^**	^**	^**	^**	^**	^**	^**	raloxifene	^**
AX5628	Rad-Ind	82	simple mastectomy	3	no	–	–	107	IIA	74%/ND / –	no	no	WBI
AX5616	Rad-Ind	82	mastectomy/wide local excision with graft closure	3	no	+	–	60	IA	91% / 16% / 0+	no	no	3D-CRT
AX5619	Rad-Ind	44	simple mastectomy	2	neoadjuvant taxol	–	–	75	IIA	67%/73% / –	ACT	tamoxifen	WBI
AX5614	Rad-Ind	^**	simple mastectomy	2	neoadjuvant taxol	–	–	^**	^**	^**	^**	^**	^**
AX5621	Rad-Ind	88	nodule excision	3	TMZ	–	–	47	IIIA	100%/ 87% / 0+	no	tamoxifen	WBI
AX5609	Sporadic	39	^**	^**	no	^**	^**
AX5627	Sporadic	75	partial resection		no	–	–
AX5630	Sporadic	70	simple mastectomy	3	^**	–	+

Angiosarcoma type: radiation-induced (Rad-Ind) and sporadic Local recurrence (LR): yes (+), no (–). Distant metastasis (DM): yes (+), no (–). Estrogen Receptor (ER)/Progesterone Receptor (PR)/Her2: non-determined (ND). Radiation treatment (XRT): whole breast (WBI), 3D-CRT (3-dimensional conformal radiotherapy). ^**: not available/unknown.